Brief: Nordic Nanovector Gets European Patent
June 3 (Reuters) - Nordic Nanovector ASA NANOV.OL :
* NORDIC NANOVECTOR: EUROPEAN PATENT GRANTED FOR BETALUTIN®
OR
HUMALUTIN® IN COMBINATION WITH ANTI-CD20 ANTIBODIES FOR TREATING
NHL
Source text for Eikon: ID:nWkr1nZ5p8
Further company coverage: NANOV.OL
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Thor Medical ASA
See all newsBrief: Thor Medical Enters Partnership Agreement With Minerva Imaging
Brief: Thor Medical Partners With Eckert & Ziegler
Brief: Thor Medical Completes Alphaone Production Facility At Herøya Industrial Park
Brief: Thor Medical Enters Multiyear Agreement With Node Pharma
Brief: Thor Medical H2 EBITDA Loss NOK 25.7 Mln